Non-Viral Vectors for Delivery of Nucleic Acid Therapies for Cancer
The research and development of non-viral gene therapy has been extensive over the past decade and has received a big push thanks to the recent successful approval of non-viral nucleic acid therapy products. Despite these developments, nucleic acid therapy applications in cancer have been limited. O...
Main Authors: | Shrey Kanvinde, Tanmay Kulkarni, Suyash Deodhar, Deep Bhattacharya, Aneesha Dasgupta |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | BioTech |
Subjects: | |
Online Access: | https://www.mdpi.com/2673-6284/11/1/6 |
Similar Items
-
Editorial: Non-viral vectors for gene therapy/nucleic acid delivery
by: Arpita Poddar, et al.
Published: (2023-10-01) -
Delivery of nucleic acids using nanomaterials
by: Yuyang Qin, et al.
Published: (2023-12-01) -
Biosafety assessment of delivery systems for clinical nucleic acid therapeutics
by: Zhimin Li, et al.
Published: (2022-04-01) -
Viral Mimicry as a Design Template for Nucleic Acid Nanocarriers
by: Ina F. de la Fuente, et al.
Published: (2021-03-01) -
Research Advances in Nucleic Acid Delivery System for Rheumatoid Arthritis Therapy
by: Xintong Zhang, et al.
Published: (2023-04-01)